The Virtual Lecture Hall Physician CME Website


Managing Opioid Misuse Disorder in Pregnancy and Neonatal Care


Managing Opioid Misuse Disorder in Pregnancy and Neonatal Care

CME Certificate Fee: $25.00 (USD) for certificate
1.00 AMA PRA Category 1 Credit(s)TM

Estimated time to complete this activity: 1.00 hours

Author(s)/Editor(s): Marc Ellsworth, MD and Madison Hustedt, MD
DISCLOSURE STATEMENT: All author(s), contributor(s), editor(s), and CME Office Reviewer(s) state that they do not have any financial arrangements with commercial interests that could constitute a conflict of interest.
Further Author/Editor Information | Further CME Information
Meets Special CME Requirements in: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Guam, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, U.S. Virgin Islands, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming     Learn More >>

New York Licensees: This course will NOT meet the NY pain management/palliative care/addiction requirement for prescribers.

Meets the DEA Medication Access and Training Expansion (MATE) requirement.

Outcome Objectives:

As a result of completing this activity, the participant will be better able to:

  • Identify the specific problems encountered by women using opioids during pregnancy
  • Evaluate pregnant patients with a history of maternal opioid use
  • Differentiate between maintenance options for opioid treatment during pregnancy
  • Assess when it is appropriate for a pregnant patient to undergo medically-supervised withdrawal from heroin.
  • Educate patients with opioid dependence who are considering pregnancy so that they can be referred for appropriate services
  • Determine the initial post-delivery treatment plan for an infant exposed to maternal methadone during pregnancy
  • Educate patients on appropriate ways of feeding an infant at risk of opioid withdrawal
  • Appropriately assess at-risk infants by describing the symptoms of neonatal opioid withdrawal
  • Determine appropriate discharge expectations for an at-risk infant not needing pharmacologic treatment for withdrawal

Learning Format: Case-based, interactive online course, including mandatory assessment questions (number of questions varies by course or module). Please also read the Technical Requirements.

CME Sponsor: University of Arizona College of Medicine - Tucson
Credit Designation and Accreditation Statements >>
Current CME Approval Period: October 20, 2021 - October 19, 2024
Original Release Date: October 20, 2017
Most Recent Review by Author: October 20, 2021
Most Recent Review by CME Sponsor: October 20, 2021
Financial Support Received: Supported by Grant Number 1U17CE002717-01, funded by the Centers for Disease Control and Prevention. Contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.
Managing Opioid Misuse Disorder in Pregnancy and Neonatal Care
1.00 AMA PRA Category 1 Credit(s)TM
Current CME Approval Period: October 20, 2021 - October 19, 2024
Financial Support Received: Supported by Grant Number 1U17CE002717-01, funded by the Centers for Disease Control and Prevention. Contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.

ACCME/AMA PRA Accreditation Statement

The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine - Tucson designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


CME Office Contact Information and CME Disclosure

The University of Arizona College of Medicine - Tucson
Office of Continuing Medical Education
520-626-7832
uofacme@email.arizona.edu

The following University of Arizona College of Medicine - Tucson CME Reviewers, Activity Directors, or Planning Committee Members have no relevant financial relationships with commercial interests that could constitute a conflict of interest with the proposed activity:

Robert Amend, M.Ed.
Randa Kutob, MD

Managing Opioid Misuse Disorder in Pregnancy and Neonatal Care
About the Authors

Marc Ellsworth, MD
Dr. Ellsworth is a practicing neonatologist in Phoenix, Arizona. He completed a Pediatric residency and Neonatal Medicine fellowship at the Mayo Clinic in Rochester, MN. Dr. Ellsworth has made contributions to a number of publications with an interest in QT prolongation and pulmonary hypertension.

Disclosure: Dr. Ellsworth states that he does not have any financial arrangements that could constitute a conflict of interest.

Madison Hustedt, MD
Dr. Hustedt is a Junior Fellow of the American College of Obstetricians and Gynecologists and will soon be a practicing obstetrician-gynecologist in the Phoenix, Arizona area. She is currently a chief resident in the University of Arizona College of Medicine – Phoenix Obstetrics and Gynecology program. She has clinical and research interests in shoulder dystocia, salpingectomy with hysterectomy, and maternal fetal medicine topics.

Disclosure: Dr. Hustedt states that she does not have any financial arrangements that could constitute a conflict of interest.

About the Reviewers/Editors

Daniel Derksen, MD
Dr. Derksen is the Walter H. Pearce Endowed Chair and Director of the University of Arizona (UA) Center for Rural Health (AzCRH). He is also Professor in the Public Health Policy and Management Program at UA's Mel and Enid Zuckerman College of Public Health. As AzCRH Director, he oversees the State Office of Rural Health (AzSORH), the Rural Hospital Flexibility Program (AzFlex), the Small Rural Hospital Improvement Program (AzSHIP), and the AzCRH Navigator Consortium.

Disclosure: Dr. Derksen states that he does not have any financial arrangements that could constitute a conflict of interest.

Barbara Ianni, DO
Dr. Ianni is a practicing neonatologist in Phoenix, Arizona. She is also Clinical Associate Professor of Child Health at the University of Arizona College of Medicine - Phoenix, Chief of Pediatrics, and Sub-Section Chief of Neonatology. She completed a fellowship in Neonatology at Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine. She has practiced as a clinical assistant professor of pediatrics as well as director of the neonatal intensive care unit. She is a fellow of both the American Academy of Pediatrics and the American College of Osteopathic Pediatricians (ACOP). She serves as Chairman of the 2001 ACOP Perinatal Meeting. Dr. Ianni has made contributions to a number of publications with an interest in neonatal infection and fetal nutrition.

Disclosure: Dr. Ianni states that she does not have any financial arrangements that could constitute a conflict of interest.

Randa Kutob, MD
Dr. Kutob is an Associate Professor of Family and Community Medicine at the University of Arizona College of Medicine-Tucson and Director of the Office of Continuing Medical Education. She is a board-certified Family Medicine physician and Diplomate of the American Board of Obesity Medicine with extensive teaching, clinical work, and research in the arena of cross-cultural care and chronic disease prevention and treatment.

Disclosure: Dr. Kutob states that she does not have any financial arrangements that could constitute a conflict of interest.

Roman Starikov, MD FACOG
Dr. Starikov is a practicing obstetrician-gynecologist in Phoenix, Arizona. He completed a fellowship in Maternal Fetal Medicine at Women and Infants Hospital of Rhode Island, Brown University School of Medicine. Dr. Starikox has made contributions to a number of publications on subjects with significant research in to the effect of diabetes in pregnancy.

Disclosure: Dr. Starikov states that he does not have any financial arrangements that could constitute a conflict of interest.

Managing Opioid Misuse Disorder in Pregnancy and Neonatal Care
Ratings (2128 responses)
How would you rate this program overall?
Average Rating: 4.00/5.00
How well were the learning objectives of this program met?
Average Rating: 4.26/5.00
User Comments
by Hidden | Apr 1, 2024
please if there is any update on prescription requirements for buprenorphine- state specifics
by June Stevens | Nov 24, 2023
I enjoyed the format of the training. Case studies are much more clinically relevant
by Hidden | Apr 19, 2023
describe treatment of NAS if necessary
by Cristian Robiou | Mar 22, 2023
My negative answers above are explain by the fact that, as a practicing specialized surgical pathologist who doesn't see patients or prescribe medications, this type of courses are clinically irrelevant and should be exonerated.
by Hidden | Mar 8, 2023
Thank you for providing state-specific content. I found that to be very helpful.
by Richard Dawson | Feb 24, 2023
Yes
Managing Opioid Misuse Disorder in Pregnancy and Neonatal Care
This course meets general AMA PRA Category 1 CME Credit(s)TM requirements in states that have a CME requirement.

Based on information from state licensing authorities, this program meets special CME requirements in these states:

Alabama Controlled Substance Prescribing Practices CME
Alabama DEA Medication Access and Training Expansion (MATE)
Alaska DEA Medication Access and Training Expansion (MATE)
Alaska Pain Management, Opioid Use, and Addiction CME
Arizona Opioid-Related, Substance Use-Related, or Addiction-Related CME
Arizona DEA Medication Access and Training Expansion (MATE)
Arkansas DEA Medication Access and Training Expansion (MATE)
California DEA Medication Access and Training Expansion (MATE)
California Controlled Substance Education (Physician Assistant CME Requirement)
Required for PAs, not MD/DOs.
Colorado DEA Medication Access and Training Expansion (MATE)
Connecticut DEA Medication Access and Training Expansion (MATE)
Connecticut Behavioral Health CME
Delaware Controlled Substance Prescribing Practices CME
Delaware DEA Medication Access and Training Expansion (MATE)
District of Columbia Public Health Topics CME
District of Columbia DEA Medication Access and Training Expansion (MATE)
Florida DEA Medication Access and Training Expansion (MATE)
Georgia DEA Medication Access and Training Expansion (MATE)
Georgia Controlled Substance Prescribing Practices CME
Guam DEA Medication Access and Training Expansion (MATE)
Hawaii DEA Medication Access and Training Expansion (MATE)
Idaho DEA Medication Access and Training Expansion (MATE)
Illinois Safe Opioid Prescribing Practices CME
Illinois DEA Medication Access and Training Expansion (MATE)
Indiana DEA Medication Access and Training Expansion (MATE)
Indiana Opioid Prescribing and Opioid Abuse CME
Iowa DEA Medication Access and Training Expansion (MATE)
Kansas DEA Medication Access and Training Expansion (MATE)
Maine Prescribing of Opioid Medication CME
Maine DEA Medication Access and Training Expansion (MATE)
Maryland Prescribing or Dispensing of Controlled Substances CME (i.e., OCSA CE Requirement)
Maryland DEA Medication Access and Training Expansion (MATE)
Massachusetts Risk Management CME
Massachusetts Opioid Education/Pain Management CME
May be counted as risk management credits.
Massachusetts DEA Medication Access and Training Expansion (MATE)
Michigan DEA Medication Access and Training Expansion (MATE)
Michigan Pain and Symptom Management CME
Minnesota DEA Medication Access and Training Expansion (MATE)
Mississippi DEA Medication Access and Training Expansion (MATE)
Mississippi Prescribing Controlled Substances CME
Missouri DEA Medication Access and Training Expansion (MATE)
Montana DEA Medication Access and Training Expansion (MATE)
Nebraska Controlled Substances Continuing Competency CME
Nebraska DEA Medication Access and Training Expansion (MATE)
Nevada Misuse and Abuse of Controlled Substances; Prescribing of Opioids; or Addiction CME
Nevada DEA Medication Access and Training Expansion (MATE)
New Hampshire DEA Medication Access and Training Expansion (MATE)
New Jersey Prescription Opioids CME
New Jersey DEA Medication Access and Training Expansion (MATE)
New Mexico DEA Medication Access and Training Expansion (MATE)
New Mexico Pain Management CME
New York DEA Medication Access and Training Expansion (MATE)
North Carolina DEA Medication Access and Training Expansion (MATE)
North Carolina Controlled Substance Prescribing CME
North Dakota DEA Medication Access and Training Expansion (MATE)
Oklahoma DEA Medication Access and Training Expansion (MATE)
Oregon DEA Medication Access and Training Expansion (MATE)
Pennsylvania DEA Medication Access and Training Expansion (MATE)
Pennsylvania Pain Management / Prescribing or Dispensing of Opioids CME
Puerto Rico DEA Medication Access and Training Expansion (MATE)
Rhode Island DEA Medication Access and Training Expansion (MATE)
South Carolina DEA Medication Access and Training Expansion (MATE)
South Carolina Safe Prescribing and Monitoring of Controlled Substances CME
South Dakota DEA Medication Access and Training Expansion (MATE)
Tennessee DEA Medication Access and Training Expansion (MATE)
Tennessee Controlled Substance Prescribing CME
Texas Medical Ethics / Professional Responsibility CME
Texas DEA Medication Access and Training Expansion (MATE)
U.S. Virgin Islands DEA Medication Access and Training Expansion (MATE)
Utah DEA Medication Access and Training Expansion (MATE)
Utah Controlled Substance Prescribing CME
Vermont Prescribing of Controlled Substances CME
Vermont DEA Medication Access and Training Expansion (MATE)
Virginia Pain Management and the Responsible Prescribing of Controlled Substances CME
Virginia DEA Medication Access and Training Expansion (MATE)
Washington Opioid Prescribing CME
Washington DEA Medication Access and Training Expansion (MATE)
West Virginia DEA Medication Access and Training Expansion (MATE)
West Virginia DEA Medication Access and Training Expansion (MATE)
Wisconsin DEA Medication Access and Training Expansion (MATE)
Wyoming DEA Medication Access and Training Expansion (MATE)
Wyoming Responsible Prescribing of Controlled Substances CME

View other courses meeting Special State Requirements
Managing Opioid Misuse Disorder in Pregnancy and Neonatal Care
Technical Requirements

This web-based activity is offered online and requires an always-on connection to the Internet (the activity cannot be downloaded). The activity works on PC or Mac computers and most tablet computers. The activity should work with the newer versions of major Internet browsers, including Edge, Chrome, Safari, and Firefox. JavaScript should be enabled in all browsers, and Popups and first party cookies need to be accepted from www.VLH.com. You should also have the latest, free Adobe Reader installed for reading documents.

For additional information, read the Technical Assistance FAQ.

The University of Arizona College of Medicine Home  |  Feedback  |  Privacy Policy  |  E-mail Policy  |  Refund Policy  |  Terms of Use  |  Contact

All contents copyright © 1998 - 2024 Arizona Board of Regents unless otherwise noted